CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-25 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +112,470 | 112,470 | ||
| 2022-02-25 | Lehr Martin A. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +254,300 | 254,300 | ||
| 2022-02-15 | Dick Evan G. Former Section 16 officer | Grant or award · Stock Option (right to buy) | +29,223 | 29,223 | ||
| 2022-02-15 | Rencher William F. Former Section 16 officer | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2021-12-16 | Lehr Martin A. Chief Executive Officer | Purchase | +13,000 | $3.22 | $42K | 820,190 |
| 2021-11-01 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +52,753 | 52,753 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Other acquisition | +52,680 | $7.14 | $376K | 0 |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion | +210,715 | 210,715 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion | +586,475 | 797,190 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Purchase | +10,000 | $5.00 | $50K | 807,190 |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Other acquisition · Warrant (right to buy) | +52,680 | 0 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion · Series A Preferred Stock | −210,715 | 7 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion · Series Seed Preferred Stock | −586,475 | 1 | ||
| 2021-10-22 | Dick Evan G. SVP of R&D | Conversion | +26,587 | 82,960 | ||
| 2021-10-22 | Dick Evan G. SVP of R&D | Conversion · Series Seed Preferred Stock | −26,587 | 0 | ||
| 2021-10-22 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | +3,000 | $5.00 | $15K | 3,000 |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Purchase | +10,000 | $5.00 | $50K | 99,583 |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Other acquisition | +52,680 | $7.14 | $376K | 52,680 |
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion | +210,722 | 263,402 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion | +586,476 | 849,878 |
Page 4 of 5 · 85 trades